SPDR S&P Biotech ETF $XBI Stock Purchased by Valeo Financial Advisors LLC

Valeo Financial Advisors LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 159.8% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 19,221 shares of the exchange traded fund’s stock after buying an additional 11,822 shares during the quarter. Valeo Financial Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $3,031,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Avoro Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $256,053,000. Bank of America Corp DE boosted its holdings in SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after buying an additional 1,700,851 shares in the last quarter. OMERS ADMINISTRATION Corp boosted its holdings in SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after buying an additional 1,187,907 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in SPDR S&P Biotech ETF by 61.4% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 691,000 shares of the exchange traded fund’s stock worth $84,254,000 after buying an additional 263,000 shares during the period. Finally, Main Street Research LLC grew its position in SPDR S&P Biotech ETF by 57.4% during the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock worth $72,484,000 after buying an additional 206,953 shares during the period.

SPDR S&P Biotech ETF Stock Performance

XBI stock traded down $1.52 during midday trading on Thursday, hitting $148.71. 9,089,923 shares of the stock were exchanged, compared to its average volume of 9,128,042. The stock’s 50-day moving average price is $158.50 and its 200-day moving average price is $145.70. The stock has a market cap of $9.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a fifty-two week low of $103.43 and a fifty-two week high of $169.89.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.